BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 17014950)

  • 1. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review.
    Mariappan P; Alhasso A; Ballantyne Z; Grant A; N'Dow J
    Eur Urol; 2007 Jan; 51(1):67-74. PubMed ID: 17014950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.
    Mariappan P; Ballantyne Z; N'Dow JM; Alhasso AA
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004742. PubMed ID: 16034945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial.
    Millard RJ; Moore K; Rencken R; Yalcin I; Bump RC;
    BJU Int; 2004 Feb; 93(3):311-8. PubMed ID: 14764128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine: a new approach for treating stress urinary incontinence.
    Moore K
    Int J Gynaecol Obstet; 2004 Jul; 86 Suppl 1():S53-62. PubMed ID: 15302567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence.
    Dmochowski RR; Miklos JR; Norton PA; Zinner NR; Yalcin I; Bump RC;
    J Urol; 2003 Oct; 170(4 Pt 1):1259-63. PubMed ID: 14501737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duloxetine in women awaiting surgery.
    Drutz H
    BJOG; 2006 May; 113 Suppl 1():17-21. PubMed ID: 16529565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duloxetine for mild to moderate postprostatectomy incontinence: preliminary results of a randomised, placebo-controlled trial.
    Cornu JN; Merlet B; Ciofu C; Mouly S; Peyrat L; Sèbe P; Yiou R; Vallancien G; Debrix I; Laribi K; Cussenot O; Haab F
    Eur Urol; 2011 Jan; 59(1):148-54. PubMed ID: 21030144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of duloxetine in stress urinary incontinence: a systematic review and meta-analysis.
    Li J; Yang L; Pu C; Tang Y; Yun H; Han P
    Int Urol Nephrol; 2013 Jun; 45(3):679-86. PubMed ID: 23504618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome.
    Häuser W; Urrútia G; Tort S; Uçeyler N; Walitt B
    Cochrane Database Syst Rev; 2013 Jan; (1):CD010292. PubMed ID: 23440848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence.
    van Kerrebroeck P; Abrams P; Lange R; Slack M; Wyndaele JJ; Yalcin I; Bump RC;
    BJOG; 2004 Mar; 111(3):249-57. PubMed ID: 14961887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
    Welsch P; Üçeyler N; Klose P; Walitt B; Häuser W
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD010292. PubMed ID: 29489029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine: in stress urinary incontinence.
    McCormack PL; Keating GM
    Drugs; 2004; 64(22):2567-73; discussion 2574-5. PubMed ID: 15516154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence.
    Zinner NR
    Expert Opin Investig Drugs; 2003 Sep; 12(9):1559-66. PubMed ID: 12943499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial management of stress urinary incontinence: pelvic floor muscle training and duloxetine.
    Freeman RM
    BJOG; 2006 May; 113 Suppl 1():10-6. PubMed ID: 16529564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine versus placebo in the treatment of stress urinary incontinence.
    Norton PA; Zinner NR; Yalcin I; Bump RC;
    Am J Obstet Gynecol; 2002 Jul; 187(1):40-8. PubMed ID: 12114886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of duloxetine in elderly women with stress urinary incontinence or stress-predominant mixed urinary incontinence.
    Schagen van Leeuwen JH; Lange RR; Jonasson AF; Chen WJ; Viktrup L
    Maturitas; 2008 Jun; 60(2):138-47. PubMed ID: 18547757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrical stimulation with non-implanted devices for stress urinary incontinence in women.
    Stewart F; Berghmans B; Bø K; Glazener CM
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD012390. PubMed ID: 29271482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on duloxetine for the management of stress urinary incontinence.
    Basu M; Duckett JR
    Clin Interv Aging; 2009; 4():25-30. PubMed ID: 19503763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Duloxetine. A new preparation for patients with urinary incontinence].
    Walter S
    Ugeskr Laeger; 2005 Nov; 167(48):4553-5. PubMed ID: 16324435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of Duloxetine in the treatment of male stress urinary incontinence.
    Fink KG; Huber J; Würnschimmel E; Schmeller NT
    Wien Med Wochenschr; 2008; 158(3-4):116-8. PubMed ID: 18330528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.